Evaluating Results of Neusidl Corneal Inserter in Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK)
NCT ID: NCT01357122
Last Updated: 2011-05-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
100 participants
INTERVENTIONAL
2009-07-31
2015-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Corneal Endothelium Delivery Instrument
NCT00874835
OCT-guided DSAEK Graft Shaping and Smoothing
NCT01586234
Descemet Endothelial Thickness Comparison Trial
NCT02373137
Prognosis of Posterior Lamellar Keratoplasty, an Observational Cohort Study
NCT06859411
Visual Outcomes Following Descemet Stripping Automated Endothelial Keratoplasty
NCT03685734
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NCI Insertion
NCI Insertion
DSAEK surgery will be performed using the NCI to insert the donor tissue.
Standard Forceps Insertion
Standard Forceps Insertion
DSAEK surgery will be performed using forceps to insert the donor tissue. This is our long-established technique for DSAEK, with well-documented excellent results.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NCI Insertion
DSAEK surgery will be performed using the NCI to insert the donor tissue.
Standard Forceps Insertion
DSAEK surgery will be performed using forceps to insert the donor tissue. This is our long-established technique for DSAEK, with well-documented excellent results.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A diagnosis of Fuchs' Corneal Endothelial Dystrophy
Exclusion Criteria
* Diagnosis of advanced glaucomatous disease
* Diagnosis of significant retinal disease
* Diagnosis of any other corneal dystrophy
* Previous corneal transplant surgery
* Previous glaucoma surgery
* Previous retinal surgery
* Previous refractive surgery
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Devers Eye Institute
OTHER
Lions Eye Bank of Oregon Vision Research Laboratory
UNKNOWN
Fischer Surgical, Inc.
INDUSTRY
Legacy Health System
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Deverse Eye Institute
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark A Terry, MD
Role: PRINCIPAL_INVESTIGATOR
Devers Eye Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Devers Eye Institute
Portland, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LEBO-2009-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.